ArticleIn vivo (Athens, Greece)

C-reactive Protein Is a Prognostic Factor for Survival in Metastatic Upper Tract Urothelial Carcinoma Patients Receiving Pembrolizumab.

Hirotaka Nagasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.